Xamoterol in severe heart failure
- 25 August 1990
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 336 (8713) , 517-518
- https://doi.org/10.1016/0140-6736(90)92078-v
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Hemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol in relation to plasma norepinephrine levels during exercise in patients with left ventricular dysfunction.Circulation, 1987
- Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure.Circulation, 1984
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJournal of the American College of Cardiology, 1983
- DOUBLE-BLIND TRIAL OF CHRONIC ORAL BETA BLOCKADE IN CONGESTIVE CARDIOMYOPATHYThe Lancet, 1981
- Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.Circulation, 1979
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975